LEMKEY JOHN G (Chief Financial Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/17/2020ACC: 0001209191-20-024776
Officer· Chief Financial Officer
Since Jun 2018
+102.00
Net shares
Net buyer
$1.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
102.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+51.00
Price / share
$22.82
Trade value
$1.16K
% of position
2.0%
4/15/2020
2.52K→2.57K
Total
Net shares
+51.00
Net value
$1.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2020 | A · Award | +51.00 | $22.82 | $1.16K | 2.0% | 2.52K | 2.57K |
| Total | +51.00 | $1.16K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
51.00 shares
Shares
+51.00
Strike price
26.85
Held after
51.00
Exercisable
—
4/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock51.00 shares | 4/15/2020 | A · Award | +51.00 | 26.85 | — | 51.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned14.08M
Total
14.08M indirect14.08M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.08M | Indirect |
| Total | 14.08M | 14.08M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported